Loading…
Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment
Background Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review o...
Saved in:
Published in: | Transplant infectious disease 2014-04, Vol.16 (2), p.270-278 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3 |
container_end_page | 278 |
container_issue | 2 |
container_start_page | 270 |
container_title | Transplant infectious disease |
container_volume | 16 |
creator | Schieffelin, J.S. Garcia-Diaz, J.B. Loss Jr, G.E. Beckman, E.N. Keller, R.A. Staffeld-Coit, C. Garces, J.C. Pankey, G.A. |
description | Background
Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.
Methods
Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses.
Results
The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses.
Conclusions
As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment. |
doi_str_mv | 10.1111/tid.12197 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1520388931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1520388931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</originalsourceid><addsrcrecordid>eNqNkU9vFCEYhydGY__owS9gJvFSk07LCwwD3pqqa5Om9rDVxAthGdilzsAIM6nz7WW7bQ8mJnLhDTzPL5BfUbwBdAJ5nY6uPQEMonlW7AMRoiKI4ef3M68wbshecZDSLULQCCpeFnuYMsw5EvvFfL1RJmzmYRP6WYfkUmknv1Zd6bw1enTBpzyWKXSuLUNcK1-OUfk0dMqPZTTaDc74MX0odee809kcokn5SG3l43JQ4yZ0YT0fl8q3WTZq7PP1q-KFVV0yrx_2w-Lm86fl-Zfq8uvi4vzsstJUoKZSlCvNjOaCEwFIMQuIEVKvcM3BWm5Ua6lVRgtLG6IJBdBM14AxsxjQihwWR7vcIYZfk0mj7F3SpsvvN2FKEmqMCOeCwH-gQCmhDeCMvvsLvQ1T9PkjW4oQELhhmXq_o3QMKUVj5RBdr-IsAcltdTJXJ--ry-zbh8Rp1Zv2iXzsKgOnO-DOdWb-d5JcXnx8jKx2hkuj-f1kqPhTsoY0tfx-tZD46hshC_pDLskfzkizMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1513319276</pqid></control><display><type>article</type><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</creator><creatorcontrib>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</creatorcontrib><description>Background
Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.
Methods
Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses.
Results
The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses.
Conclusions
As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</description><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/tid.12197</identifier><identifier>PMID: 24628809</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Alternaria ; Amphotericin B - therapeutic use ; Antifungal Agents - therapeutic use ; Aureobasidium ; Brain Abscess - drug therapy ; Brain Abscess - microbiology ; Chaetomium ; Cladosporium ; Coniothyrium ; Debridement ; dematiaceous fungi ; Exophiala ; Female ; Humans ; Immunosuppression - adverse effects ; Itraconazole - therapeutic use ; Lung Abscess - drug therapy ; Lung Abscess - microbiology ; Male ; Middle Aged ; Opportunistic Infections - microbiology ; Opportunistic Infections - therapy ; Organ Transplantation - adverse effects ; phaeohyphomycosis ; Phaeohyphomycosis - microbiology ; Phaeohyphomycosis - therapy ; Phoma ; Retrospective Studies ; Time Factors ; transplantation ; Voriconazole - therapeutic use ; Wangiella ; Young Adult</subject><ispartof>Transplant infectious disease, 2014-04, Vol.16 (2), p.270-278</ispartof><rights>2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><rights>2014 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</citedby><cites>FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24628809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schieffelin, J.S.</creatorcontrib><creatorcontrib>Garcia-Diaz, J.B.</creatorcontrib><creatorcontrib>Loss Jr, G.E.</creatorcontrib><creatorcontrib>Beckman, E.N.</creatorcontrib><creatorcontrib>Keller, R.A.</creatorcontrib><creatorcontrib>Staffeld-Coit, C.</creatorcontrib><creatorcontrib>Garces, J.C.</creatorcontrib><creatorcontrib>Pankey, G.A.</creatorcontrib><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><description>Background
Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.
Methods
Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses.
Results
The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses.
Conclusions
As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</description><subject>Adult</subject><subject>Aged</subject><subject>Alternaria</subject><subject>Amphotericin B - therapeutic use</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aureobasidium</subject><subject>Brain Abscess - drug therapy</subject><subject>Brain Abscess - microbiology</subject><subject>Chaetomium</subject><subject>Cladosporium</subject><subject>Coniothyrium</subject><subject>Debridement</subject><subject>dematiaceous fungi</subject><subject>Exophiala</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppression - adverse effects</subject><subject>Itraconazole - therapeutic use</subject><subject>Lung Abscess - drug therapy</subject><subject>Lung Abscess - microbiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Opportunistic Infections - microbiology</subject><subject>Opportunistic Infections - therapy</subject><subject>Organ Transplantation - adverse effects</subject><subject>phaeohyphomycosis</subject><subject>Phaeohyphomycosis - microbiology</subject><subject>Phaeohyphomycosis - therapy</subject><subject>Phoma</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>transplantation</subject><subject>Voriconazole - therapeutic use</subject><subject>Wangiella</subject><subject>Young Adult</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkU9vFCEYhydGY__owS9gJvFSk07LCwwD3pqqa5Om9rDVxAthGdilzsAIM6nz7WW7bQ8mJnLhDTzPL5BfUbwBdAJ5nY6uPQEMonlW7AMRoiKI4ef3M68wbshecZDSLULQCCpeFnuYMsw5EvvFfL1RJmzmYRP6WYfkUmknv1Zd6bw1enTBpzyWKXSuLUNcK1-OUfk0dMqPZTTaDc74MX0odee809kcokn5SG3l43JQ4yZ0YT0fl8q3WTZq7PP1q-KFVV0yrx_2w-Lm86fl-Zfq8uvi4vzsstJUoKZSlCvNjOaCEwFIMQuIEVKvcM3BWm5Ua6lVRgtLG6IJBdBM14AxsxjQihwWR7vcIYZfk0mj7F3SpsvvN2FKEmqMCOeCwH-gQCmhDeCMvvsLvQ1T9PkjW4oQELhhmXq_o3QMKUVj5RBdr-IsAcltdTJXJ--ry-zbh8Rp1Zv2iXzsKgOnO-DOdWb-d5JcXnx8jKx2hkuj-f1kqPhTsoY0tfx-tZD46hshC_pDLskfzkizMA</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Schieffelin, J.S.</creator><creator>Garcia-Diaz, J.B.</creator><creator>Loss Jr, G.E.</creator><creator>Beckman, E.N.</creator><creator>Keller, R.A.</creator><creator>Staffeld-Coit, C.</creator><creator>Garces, J.C.</creator><creator>Pankey, G.A.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</title><author>Schieffelin, J.S. ; Garcia-Diaz, J.B. ; Loss Jr, G.E. ; Beckman, E.N. ; Keller, R.A. ; Staffeld-Coit, C. ; Garces, J.C. ; Pankey, G.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Alternaria</topic><topic>Amphotericin B - therapeutic use</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aureobasidium</topic><topic>Brain Abscess - drug therapy</topic><topic>Brain Abscess - microbiology</topic><topic>Chaetomium</topic><topic>Cladosporium</topic><topic>Coniothyrium</topic><topic>Debridement</topic><topic>dematiaceous fungi</topic><topic>Exophiala</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppression - adverse effects</topic><topic>Itraconazole - therapeutic use</topic><topic>Lung Abscess - drug therapy</topic><topic>Lung Abscess - microbiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Opportunistic Infections - microbiology</topic><topic>Opportunistic Infections - therapy</topic><topic>Organ Transplantation - adverse effects</topic><topic>phaeohyphomycosis</topic><topic>Phaeohyphomycosis - microbiology</topic><topic>Phaeohyphomycosis - therapy</topic><topic>Phoma</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>transplantation</topic><topic>Voriconazole - therapeutic use</topic><topic>Wangiella</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schieffelin, J.S.</creatorcontrib><creatorcontrib>Garcia-Diaz, J.B.</creatorcontrib><creatorcontrib>Loss Jr, G.E.</creatorcontrib><creatorcontrib>Beckman, E.N.</creatorcontrib><creatorcontrib>Keller, R.A.</creatorcontrib><creatorcontrib>Staffeld-Coit, C.</creatorcontrib><creatorcontrib>Garces, J.C.</creatorcontrib><creatorcontrib>Pankey, G.A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schieffelin, J.S.</au><au>Garcia-Diaz, J.B.</au><au>Loss Jr, G.E.</au><au>Beckman, E.N.</au><au>Keller, R.A.</au><au>Staffeld-Coit, C.</au><au>Garces, J.C.</au><au>Pankey, G.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2014-04</date><risdate>2014</risdate><volume>16</volume><issue>2</issue><spage>270</spage><epage>278</epage><pages>270-278</pages><issn>1398-2273</issn><eissn>1399-3062</eissn><abstract>Background
Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.
Methods
Cases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses.
Results
The time from transplantation to onset of infection ranged from 2 months to 11 years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non‐sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses.
Conclusions
As the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>24628809</pmid><doi>10.1111/tid.12197</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1398-2273 |
ispartof | Transplant infectious disease, 2014-04, Vol.16 (2), p.270-278 |
issn | 1398-2273 1399-3062 |
language | eng |
recordid | cdi_proquest_miscellaneous_1520388931 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult Aged Alternaria Amphotericin B - therapeutic use Antifungal Agents - therapeutic use Aureobasidium Brain Abscess - drug therapy Brain Abscess - microbiology Chaetomium Cladosporium Coniothyrium Debridement dematiaceous fungi Exophiala Female Humans Immunosuppression - adverse effects Itraconazole - therapeutic use Lung Abscess - drug therapy Lung Abscess - microbiology Male Middle Aged Opportunistic Infections - microbiology Opportunistic Infections - therapy Organ Transplantation - adverse effects phaeohyphomycosis Phaeohyphomycosis - microbiology Phaeohyphomycosis - therapy Phoma Retrospective Studies Time Factors transplantation Voriconazole - therapeutic use Wangiella Young Adult |
title | Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A45%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phaeohyphomycosis%20fungal%20infections%20in%20solid%20organ%20transplant%20recipients:%20clinical%20presentation,%20pathology,%20and%20treatment&rft.jtitle=Transplant%20infectious%20disease&rft.au=Schieffelin,%20J.S.&rft.date=2014-04&rft.volume=16&rft.issue=2&rft.spage=270&rft.epage=278&rft.pages=270-278&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/tid.12197&rft_dat=%3Cproquest_cross%3E1520388931%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4907-a48ac6ec8983910a6f106335b2581ff8eadf4faec9f473c3411c6c51226f210b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1513319276&rft_id=info:pmid/24628809&rfr_iscdi=true |